Mitochondrially targeted compounds and their impact on cellular bioenergetics

Redox Biology

Volumn 1, Issue 1, 2013, Pages 86-93

  Reily, Colin ^a   Mitchell, Tanecia ^a   Chacko, Balu K ^a   Benavides, Gloria A ^a   Murphy, Michael P ^b   Darley Usmar, Victor M ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Extracellular flux; Mitochondria; Mitochondrial targeted compounds; MitoQ; Redox; Respiration

Indexed keywords

ANTIOXIDANT; CATION; FUNCTIONAL GROUP; MITOCHONDRIALLY TARGETED COMPOUND; MITOE; MITOQUINONE; MITOTEMPOL; PHOSPHORUS DERIVATIVE; TRIPHENYLPHOSPHONIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOENERGY; CELL CULTURE; CELL METABOLISM; CONCENTRATION RESPONSE; DRUG CONJUGATION; DRUG TARGETING; MESANGIUM CELL; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

EID: 84879481183     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2012.11.009     Document Type: Article

References (32)

1. Higdon A., Diers A.R., Oh J.Y., Landar A., Darley-Usmar V.M. Cell signalling by reactive lipid species: new concepts and molecular mechanisms. The Biochemical Journal 2012, 442:453-464.
2. Higdon A.N., Benavides G.A., Chacko B.K., Ouyang X., Johnson M.S., Landar A., Zhang J., Darley-Usmar V.M. Hemin causes mitochondrial dysfunction in endothelial cells through promoting lipid peroxidation: the protective role of autophagy. American Journal of Physiology-Heart and Circulatory Physiology 2012, 302:H1394-1409.
3. Landar A., Zmijewski J.W., Dickinson D.A., Le Goffe C., Johnson M.S., Milne G.L., Zanoni G., Vidari G., Morrow J.D., Darley-Usmar V.M. Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. American Journal of Physiology-Heart and Circulatory Physiology 2006, 290:H1777-1787.
4. Diers A.R., Higdon A.N., Ricart K.C., Johnson M.S., Agarwal A., Kalyanaraman B., Landar A., Darley-Usmar V.M. Mitochondrial targeting of the electrophilic lipid 15-deoxy-Delta12,14-prostaglandin J2 increases apoptotic efficacy via redox cell signalling mechanisms. The Biochemical Journal 2010, 426:31-41.
5. Hill B.G., Benavides G.A., Lancaster J.R., Ballinger S., Dell'italia L., Zhang J., Darley-Usmar V.M. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biological Chemistry 2012, 393:1485-1512.
6. Murphy M.P. Targeting lipophilic cations to mitochondria. Biochimica Biophysica Acta 2008, 1777:1028-1031.
7. Horton K.L., Pereira M.P., Stewart K.M., Fonseca S.B., Kelley S.O. Tuning the activity of mitochondria-penetrating peptides for delivery or disruption. Chembiochem 2012, 13:476-485.
8. Gane E.J., Orr D.W., Weilert F., Keogh G.F., Gibson M., Murphy M.P., Smith R.A., Lockhart M.M., Frampton C.M., Taylor K.M. 847 phase II study of the mitochondrial antioxidant mitoquinone for hepatitis C. Journal of Hepatology 2008, 48:S318.
9. Fisher G.J., Quan T., Purohit T., Shao Y., Cho M.K., He T., Varani J., Kang S., Voorhees J.J. Collagen fragmentation promotes oxidative stress and elevates matrix metalloproteinase-1 in fibroblasts in aged human skin. American Journal of Pathology 2009, 174:101-114.
10. Adlam V.J., Harrison J.C., Porteous C.M., James A.M., Smith R.A.J., Murphy M.P., Sammut I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB Journal 2005, 19:1088-1095.
11. Mitchell T., Rotaru D., Saba H., Smith R.A., Murphy M.P., MacMillan-Crow L.A. The mitochondria-targeted antioxidant mitoquinone protects against cold storage injury of renal tubular cells and rat kidneys. Journal of Pharmacology and Experimental Therapeutics 2011, 336:682-692.
12. Orsucci D., Mancuso M., Ienco E.C., LoGerfo A., Siciliano G. Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Current Medicinal Chemistry 2011, 18:4053-4064.
13. Chacko B.K., Reily C., Srivastava A., Johnson M.S., Ye Y., Ulasova E., Agarwal A., Zinn K.R., Murphy M.P., Kalyanaraman B., Darley-Usmar V. Prevention of diabetic nephropathy in Ins2({thorn}/)(AkitaJ) mice by the mitochondria-targeted therapy MitoQ. Biochemical Journal 2010, 432:9-19.
14. Chacko B.K., Srivastava A., Johnson M.S., Benavides G.A., Chang M.J., Ye Y., Jhala N., Murphy M.P., Kalyanaraman B., Darley-Usmar V.M. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 2011, 54:153-163.
15. Nicholls D.G., Ward M.W. Mitochondrial membrane potential and neuronal glutamate excitotoxicity: mortality and millivolts. Trends in Neuroscience 2000, 23:166-174.
16. Nicholls D.G. Commentary on: 'old and new data, new issues: the mitochondrial Deltapsi' by H. Tedeschi. Biochimica Biophysica Acta 2005, 1710:63-65. discussion 66.
17. Ross M.F., Prime T.A., Abakumova I., James A.M., Porteous C.M., Smith R.A.J., Murphy M.P. Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochemical Journal 2008, 411:633-645.
18. Smith R.A.J., Porteous C.M., Gane A.M., Murphy M.P. Delivery of bioactive molecules to mitochondria invivo. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:5407-5412.
19. Smith R.A., Kelso G.F., James A.M., Murphy M.P. Targeting coenzyme Q derivatives to mitochondria. Methods in Enzymology 2004, 382:45-67.
20. Flewelling R.F., Hubbell W.L. The membrane dipole potential in a total membrane potential model. Applications to hydrophobic ion interactions with membranes. Biophysical Journal 1986, 49:541-552.
21. Millard M., Pathania D., Shabaik Y., Taheri L., Deng J., Neamati N. Preclinical evaluation of novel triphenylphosphonium salts with broad-spectrum activity. PLoS One 2010, 5:e13131.
22. Leo S., Szabadkai G., Rizzuto R. The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2+) load upon cell stimulation by inhibiting Ca(2+) efflux from the organelle. Annals of the New York Academy of Sciences 2008, 1147:264-274.
23. Rao V.A., Klein S.R., Bonar S.J., Zielonka J., Mizuno N., Dickey J.S., Keller P.W., Joseph J., Kalyanaraman B., Shacter E. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. Journal of Biological Chemistry 2010, 285:34447-34459.
24. 2 generated from electron transport chain complex I stimulates muscle differentiation. Cell Research 2011, 21:817-834.
25. Fink B.D., Herlein J.A., Yorek M.A., Fenner A.M., Kerns R.J., Sivitz W.I. Bioenergetic effects of mitochondrial-targeted coenzyme q analogs in endothelial cells. Journal of Pharmacology and Experimental Therapeutics 2012, 342:709-719.
26. Rodriguez-Cuenca S., Cocheme H.M., Logan A., Abakumova I., Prime T.A., Rose C., Vidal-Puig A., Smith A.C., Rubinsztein D.C., Fearnley I.M., Jones B.A., Pope S., Heales S.J., Lam B.Y., Neogi S.G., McFarlane I., James A.M., Smith R.A., Murphy M.P. Consequences of long-term oral administration of the mitochondria-targeted antioxidant MitoQ to wild-type mice. Free Radical Biology and Medicine 2010, 48:161-172.
27. Kelso G.F., Porteous C.M., Coulter C.V., Hughes G., Porteous W.K., Ledgerwood E.C., Smith R.A., Murphy M.P. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 2001, 276:4588-4596.
28. Trnka J., Blaikie F.H., Smith R.A., Murphy M.P. A mitochondria-targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radical Biology and Medicine 2008, 44:1406-1419.
29. Murphy M.P., Smith R.A. Drug delivery to mitochondria: the key to mitochondrial medicine. Advanced Drug Delivery Reviews 2000, 41:235-250.
30. Dranka B.P., Benavides G.A., Diers A.R., Giordano S., Zelickson B.R., Reily C., Zou L., Chatham J.C., Hill B.G., Zhang J., Landar A., Darley-Usmar V.M. Assessing bioenergetic function in response to oxidative stress by metabolic profiling. Free Radical Biology and Medicine 2011, 51:1621-1635.
31. Asin-Cayuela J., Manas A.R., James A.M., Smith R.A., Murphy M.P. Fine-tuning the hydrophobicity of a mitochondria-targeted antioxidant. FEBS Letters 2004, 571:9-16.
32. Doughan A.K., Dikalov S.I. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxidants and Redox Signalling 2007, 9:1825-1836.